Copyright
©The Author(s) 2019.
World J Hepatol. Aug 27, 2019; 11(8): 613-618
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.613
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.613
Table 1 Diseases associated to porto sinusoidal vascular liver disease
Thrombophilia |
Myeloproliferative neoplasm |
Protein S or C deficiency |
Antiphospholipid antibodies |
Lupus anticoagulant |
Factor V Leiden |
Prothrombin mutation |
Hematologic disease |
Myeloproliferative neoplasm (polycythemia vera, chronic myelogenous leukaemia, essential thrombocythemia) |
Myeloid metaplasia |
Lymphoproliferative conditions (Hodgkin’s disease, non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia and multiple myeloma) |
Spherocytosis |
Genetic disorders |
Cystic fibrosis |
Adams Oliver syndrome |
Turner‘s disease |
Autoimmune disease |
Rheumatoid arthritis |
Systemic lupus erythematosus |
Systemic sclerosis |
Scleroderma |
Gut diseases |
Celiac disease |
Inflammatory bowel disease |
Drug and toxics |
Oxaliplatin |
Azathioprine |
6-thioguanine |
Arsenic |
Busulfan |
Cytosine arabinoside |
Cyclophosphamide |
Bleomycin |
Chlorambucil |
Doxyrubicin |
Carmustine |
Acquired and congenital immunodeficiency |
Human immunodeficiency virus |
Primary antibody-deficiency syndrome |
- Citation: Gioia S, Nardelli S, Ridola L, d’Amati G, Riggio O. Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? World J Hepatol 2019; 11(8): 613-618
- URL: https://www.wjgnet.com/1948-5182/full/v11/i8/613.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i8.613